Form EFFECT CRISPR Therapeutics AG

Go back to Form EFFECT CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%

October 19, 2016 10:37 AM EDT

Today's IPO for CRISPR Therapeutics AG (Nasdaq: CRSP) opened for trading at $15 after pricing its initial public offering of 4,000,000 common shares at a public offering price of $14.00 per share.

Citigroup, Piper Jaffray and Barclays are acting as joint book-running managers for the offering.... More